Ghana vs Small island developing States (SIDS): Proportion of the target population who received a 3rd dose of
Ghana
96.0%
in 2024
Small island developing States (SIDS)
53.0%
in 2024
Ghana rank
16th
Small island developing States (SIDS) rank
30th
Proportion of the target population who received a 3rd dose of over time
- Ghana
- Small island developing States (SIDS)
How they compare
Ghana currently reports 96.0% against 53.0% in Small island developing States (SIDS), a difference of 43.0%.
That makes Ghana's figure about 1.8 times Small island developing States (SIDS)'s.
Across all 13 years both countries report, Ghana has been ahead every year.
Ghana ranks 16th and Small island developing States (SIDS) ranks 30th of 157 countries.
Ghana has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Ghana | Small island developing States (SIDS) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 88.0% | 22.2% | 65.8% | Ghana |
| 2020s | 96.8% | 49.0% | 47.8% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Ghana or Small island developing States (SIDS)?
- Ghana, at 96.0% against 53.0% in Small island developing States (SIDS) as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Ghana and Small island developing States (SIDS)?
- 43.0%, with Ghana ahead.
- How many years of comparable data are there for Ghana and Small island developing States (SIDS)?
- 13 years are reported by both, from 2012 to 2024.
- How do Ghana and Small island developing States (SIDS) rank globally for proportion of the target population who received a 3rd dose of?
- Ghana ranks 16th and Small island developing States (SIDS) ranks 30th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.